Lek once again recognized as the most reputable employer in Slovenia

  • Lek has been recognized as the  most reputable employer 2020, according to the opinion of the participants in a  survey measuring the reputation of employers and undertaken by the recruitment  portal MojeDelo.com.
  • The company received the title  of the most reputable employer for the second consecutive year, for the third  time in total. At the end of last year, Novartis in Slovenia also obtained the  international »Top Employer 2021« certificate for the best employer.
  • Novartis in Slovenia develops  an unbossed culture that embraces innovation, curiosity and diversity and  inclusion.
22. 4. 2021

Lek is the recipient of the prestigious title ‘the most reputable employer’, presented by the recruitment portal MojeDelo.com. The survey involves experts from academia and business, as well as students and candidates in the job market, who assess the reputation of Slovenian employers. This year, the survey attracted 12000 respondents who chose Novartis in Slovenia as the absolute winner and the winner of individual five categories. Lek received the title for the second year in a row, for the third time in total.

Robert Ljoljo, President of the Board of Management of Lek and Novartis Country President, Slovenia, who received the award at the virtual award ceremony, said: »The title of the most reputable employer after more than a year of confrontation with COVID-19 carries particular weight as we are aware that we have successfully endured this period because of our employees and our culture, which we have been co-creating together for a long time. We believe that motivated employees are a prerequisite for the development, progress and success of the company, therefore developing an unbossed, curious and inspiring culture based on the diversity and involvement of the individual, is our priority. I am pleased that the values we live in the company are also visible externally, which further motivates us to constantly improve the working environment for our employees and to inspire other Slovenian companies. Receiving the title for the second year in a row means that we have managed to maintain and upgrade our role as a responsible employer despite a challenging period. I am convinced that with our colleagues we will continue to build an unbossed, inclusive and agile culture, which will continue to place us at the very top of the reputable employers and pharmaceutical companies«.

Through continuous investment, Novartis in Slovenia creates the conditions for new, advanced forms of work with active work solutions that are in line with Novartis’ efforts to continuously improve the work environment. Last year, the company also introduced the Choice with Responsibility working model, which gives employees the opportunity to decide how, where and when to perform their work, depending on the nature of their work. Together with the elimination of the old hierarchical structure and the introduction of an empowered culture, their work is based on collaboration, listening and learning, which enables agility and innovation for breakthrough solutions needed to stand out in the demanding pharmaceutical market and fulfill their mission, to care for patients worldwide.

At the end of last year, Novartis in Slovenia was the first and only pharmaceutical company in Slovenia to obtain the prestigious international certificate »Top Employer 2021« for the best employer in Slovenia, as well as in Europe and globally.

* * *

Novartis is the leading provider of medicines in  Slovenia, where Lek d.d., Novartis Pharma Services Inc., Podružnica v Sloveniji and Sandoz d.d., operate. Together we are building and maintaining the reputation of a dynamic, ethical, and trusted pharmaceutical company. Lek develops, manufactures, and markets effective, safe, and high quality medicines and active pharmaceutical ingredients. With our knowledge, quality, and experience we have gained an important role in Novartis' organizational structure, especially in the Novartis Technical Operations, Global Drug Development, Novartis Business Services, and the generic division Sandoz. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We invest a great deal in the development, education, and training of our employees. Over the last nine years, the company has created more than 3,350 new job opportunities, making us one of the biggest employers in Slovenia. Novartis invested in Slovenia more than EUR 2.7 billion since 2003.

About Sandoz
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2020 sales of USD 9.6 billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.

Sandoz is on Twitter. Sign up to follow @SandozGlobal at http://twitter.com/Sandoz_Global.

About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.

* * *

This press release contains statements and  conclusions based on projections of Lek’s future business operations. These  estimates are derived from the best information currently available. In case  these forecasts prove unreliable, the actual results could prove different from those projected.

- end -

For additional information contact:
Gregor Makuc
Communications & External Engagement
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43